Linezolid Infomed

Linezolid, the active ingredient in Linezolid Infomed, is an oxazolidinone presented as an injectable solution for intravenous use. It treats serious bacterial infections such as complicated skin and soft tissue infections, community‑acquired bacterial pneumonia, nosocomial pneumonia, MRSA and VRE infections in adult patients.

GNH USA supplies Linezolid Infomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is indicated for bacterial infections that are resistant to other agents, especially those affecting the skin, lungs and resistant Gram‑positive organisms.

- Complicated skin and soft tissue infections: provides effective coverage against MRSA and other Gram‑positive pathogens. - Community‑acquired bacterial pneumonia: treats typical and atypical organisms causing pneumonia. - Nosocomial pneumonia: active against hospital‑acquired Gram‑positive bacteria including MRSA. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: eradicates MRSA strains in various infection sites. - Vancomycin‑resistant Enterococcus (VRE) infections: offers an option where alternatives are limited.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Headache: transient headache. - Thrombocytopenia: mild reduction in platelet count.

Serious or Rare Side Effects: - Myelosuppression: significant decrease in blood cell production. - Peripheral neuropathy: sensory changes with prolonged use. - Lactic acidosis: rare metabolic disturbance.

When using Linezolid, clinicians should consider several safety measures. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic dysfunction: observe liver enzymes during treatment. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Prolonged therapy (>14 days): monitor for hematologic toxicity. - Pregnancy and lactation: use only if benefits outweigh risks; safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid interacts with several drug classes that may require avoidance or close monitoring.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: may precipitate serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect. - Tyramine‑rich foods: may cause hypertensive episodes when combined with MAO inhibition.